• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Induction of erythropoietin by dietary medium-chain triacylglycerol in humans.

作者信息

Kanta Josephine M, Lundsgaard Annemarie, Schaufuss Amanda, Kleinert Maximilian, Kiens Bente, Fritzen Andreas M

机构信息

The August Krogh Section for Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.

Novo Nordisk A/S, Søborg, Denmark.

出版信息

Am J Physiol Endocrinol Metab. 2025 Feb 1;328(2):E210-E216. doi: 10.1152/ajpendo.00415.2024. Epub 2025 Jan 10.

DOI:10.1152/ajpendo.00415.2024
PMID:39792092
Abstract

Erythropoietin (EPO) is pivotal in regulating red blood cell (erythrocyte) concentrations and is primarily synthesized in the kidney. Recent research has unveiled a possible link between elevated circulating concentrations of ketone bodies (KB) and circulating EPO concentrations; however, it is not known whether nutritionally induced endogenous ketogenesis can be a stimulus to induce EPO in humans. Therefore, this study aimed to assess whether acute and chronic intake of medium-chain fatty acid-containing triacylglycerol (MCT), which rapidly enhances endogenous circulating KB, would elevate circulating EPO concentrations in humans, as indicated by prior work with exogenous KB administration. The study followed a crossover design involving 16 young men undergoing two 8-day MCT or energy-matched long-chain fatty acid-containing triacylglycerol (LCT) interventions in a randomized order. Five-hour test days were performed before and after each intervention, in which circulating KB and EPO concentrations as well as hematological parameters were assessed. Acute intake of MCT yielded a 222% sustained 5-h elevation in KB concentrations compared with LCT-with notable peak values of 0.7 ± 0.1 mmol·L (312% above basal values). Remarkably, within just 8 days of daily MCT intake an impressive 38% increase in basal, fasting plasma EPO concentrations (7.19 ± 1.14 to 9.91 ± 1.25 mIU·mL) was demonstrated. In conclusion, this study unveils a novel physiological stimulus of circulating EPO concentrations in humans, potentially offering a new dietary approach to counter anemia in cardiovascular diseases. This study is the first to assess the effects of nutritionally induced ketogenesis by acute and subchronic intake of medium-chain fatty acids on plasma erythropoietin concentrations. Medium-chain fatty acid intake increases postprandial ketone body concentrations and within only 8 days of daily intake substantially enhances basal plasma erythropoietin concentrations in young men. We therefore reveal a dietary stimulus of endogenous circulating erythropoietin concentrations in humans, with the potential to counter anemia in cardiovascular diseases.

摘要

相似文献

1
Induction of erythropoietin by dietary medium-chain triacylglycerol in humans.
Am J Physiol Endocrinol Metab. 2025 Feb 1;328(2):E210-E216. doi: 10.1152/ajpendo.00415.2024. Epub 2025 Jan 10.
2
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
3
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
4
Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.终末期肾病透析患者中重组人促红细胞生成素治疗贫血的给药频率
Cochrane Database Syst Rev. 2002(4):CD003895. doi: 10.1002/14651858.CD003895.
5
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
6
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004868. doi: 10.1002/14651858.CD004868.pub2.
7
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期与晚期使用促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004865. doi: 10.1002/14651858.CD004865.pub2.
8
Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.重组人促红细胞生成素用于透析前慢性肾衰竭患者的贫血治疗
Cochrane Database Syst Rev. 2001(4):CD003266. doi: 10.1002/14651858.CD003266.
9
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
10
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2012 Sep 12(9):CD004868. doi: 10.1002/14651858.CD004868.pub3.